-- 
Bioline RX Gets European Device Confirmation for Bl-5010 Drug

-- B y   S h a r o n   W r o b e l
-- 
2011-09-15T06:34:29Z

-- http://www.bloomberg.com/news/2011-09-15/bioline-rx-gets-european-device-confirmation-for-bl-5010-drug.html
Bioline RX Ltd. (BLRX)  said it received
European confirmation for the classification of its BL-5010 drug
to treat seborrheic keratosis skin lesions, as a medical device
Class IIa, according to a statement filed today with the Tel
Aviv Stock Exchange.  To contact the reporter on this story:
Sharon Wrobel in Tel Aviv at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Calev Ben-David at 
 cbendavid@bloomberg.net  